These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28223799)

  • 1. Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy.
    Liu HM; Zhang YF; Xie YD; Cai YF; Li BY; Li W; Zeng LY; Li YL; Yu RT
    Int J Nanomedicine; 2017; 12():1065-1083. PubMed ID: 28223799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma.
    Shi H; Sun S; Xu H; Zhao Z; Han Z; Jia J; Wu D; Lu J; Liu H; Yu R
    Int J Nanomedicine; 2020; 15():3347-3362. PubMed ID: 32494134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SiRNA-phospholipid conjugates for gene and drug delivery in cancer treatment.
    Liu H; Li Y; Mozhi A; Zhang L; Liu Y; Xu X; Xing J; Liang X; Ma G; Yang J; Zhang X
    Biomaterials; 2014 Aug; 35(24):6519-33. PubMed ID: 24797882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.
    Xiang B; Jia XL; Qi JL; Yang LP; Sun WH; Yan X; Yang SK; Cao DY; Du Q; Qi XR
    Int J Nanomedicine; 2017; 12():2385-2405. PubMed ID: 28405163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimuli-responsive release and efficient siRNA delivery in non-small cell lung cancer by a poly(l-histidine)-based multifunctional nanoplatform.
    Shi M; Zhang J; Huang Z; Chen Y; Pan S; Hu H; Qiao M; Chen D; Zhao X
    J Mater Chem B; 2020 Feb; 8(8):1616-1628. PubMed ID: 32010914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a hypoxia-triggered and hypoxic radiosensitized liposome as a doxorubicin carrier to promote synergetic chemo-/radio-therapy for glioma.
    Liu H; Xie Y; Zhang Y; Cai Y; Li B; Mao H; Liu Y; Lu J; Zhang L; Yu R
    Biomaterials; 2017 Mar; 121():130-143. PubMed ID: 28088075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer.
    Xiang B; Dong DW; Shi NQ; Gao W; Yang ZZ; Cui Y; Cao DY; Qi XR
    Biomaterials; 2013 Sep; 34(28):6976-91. PubMed ID: 23777916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balancing polymer hydrophobicity for ligand presentation and siRNA delivery in dual function CXCR4 inhibiting polyplexes.
    Wang Y; Li J; Chen Y; Oupický D
    Biomater Sci; 2015 Jul; 3(7):1114-23. PubMed ID: 26146552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of doxorubicin efficacy using liposomal anti-polo-like kinase 1 siRNA in human renal cell carcinomas.
    Sakurai Y; Hatakeyama H; Akita H; Harashima H
    Mol Pharm; 2014 Aug; 11(8):2713-9. PubMed ID: 24800640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cationic liposome and PAMAM dendrimer for delivery of anti-Plk1 siRNA in breast cancer treatment.
    Bulbake U; Kommineni N; Ionov M; Bryszewska M; Khan W
    Pharm Dev Technol; 2020 Jan; 25(1):9-19. PubMed ID: 30633621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody h-R3-dendrimer mediated siRNA has excellent endosomal escape and tumor targeted delivery ability, and represents efficient siPLK1 silencing and inhibition of cell proliferation, migration and invasion.
    Li J; Liu J; Li S; Hao Y; Chen L; Zhang X
    Oncotarget; 2016 Mar; 7(12):13782-96. PubMed ID: 26883109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
    Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
    J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer.
    Mahajan UM; Teller S; Sendler M; Palankar R; van den Brandt C; Schwaiger T; Kühn JP; Ribback S; Glöckl G; Evert M; Weitschies W; Hosten N; Dombrowski F; Delcea M; Weiss FU; Lerch MM; Mayerle J
    Gut; 2016 Nov; 65(11):1838-1849. PubMed ID: 27196585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
    Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
    J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells.
    Hu J; Wang J; Wang G; Yao Z; Dang X
    Int J Mol Med; 2016 Mar; 37(3):690-702. PubMed ID: 26782731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a Novel PEGylated Liposomal Vector for Systemic Delivery of siRNA to Solid Tumors.
    Song F; Sakurai N; Okamoto A; Koide H; Oku N; Dewa T; Asai T
    Biol Pharm Bull; 2019; 42(6):996-1003. PubMed ID: 31155597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric liposome particles with highly efficient encapsulation of siRNA and without nonspecific cell penetration suitable for target-specific delivery.
    Mokhtarieh AA; Cheong S; Kim S; Chung BH; Lee MK
    Biochim Biophys Acta; 2012 Jul; 1818(7):1633-41. PubMed ID: 22465072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted co-delivery of docetaxel and siPlk1 by herceptin-conjugated vitamin E TPGS based immunomicelles.
    Zhao J; Mi Y; Feng SS
    Biomaterials; 2013 Apr; 34(13):3411-21. PubMed ID: 23375951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
    Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
    J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of polo-like kinase 1 siRNA nanoparticles using an EGFR-PEG bispecific antibody inhibits proliferation of high-risk neuroblastoma.
    Logan A; Howard CB; Huda P; Kimpton K; Ma Z; Thurecht KJ; McCarroll JA; Moles E; Kavallaris M
    J Control Release; 2024 Mar; 367():806-820. PubMed ID: 38341177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.